Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues.

Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter JA, Sarukhan A.

Front Immunol. 2014 Mar 26;5:127. doi: 10.3389/fimmu.2014.00127. eCollection 2014. Review.

PMID:
24723924
[PubMed]
Free PMC Article
2.

Flipping the script on macrophages in leiomyosarcoma.

Edris B, Weiskopf K, Weissman IL, van de Rijn M.

Oncoimmunology. 2012 Oct 1;1(7):1202-1204.

PMID:
23170280
[PubMed]
Free PMC Article
3.

Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma.

Edris B, Weiskopf K, Volkmer AK, Volkmer JP, Willingham SB, Contreras-Trujillo H, Liu J, Majeti R, West RB, Fletcher JA, Beck AH, Weissman IL, van de Rijn M.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6656-61. doi: 10.1073/pnas.1121629109. Epub 2012 Mar 26.

PMID:
22451919
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Classification, molecular characterization, and the significance of pten alteration in leiomyosarcoma.

Grossmann AH, Layfield LJ, Randall RL.

Sarcoma. 2012;2012:380896. doi: 10.1155/2012/380896. Epub 2012 Feb 15.

PMID:
22448121
[PubMed]
Free PMC Article
5.

The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines.

Morandi A, Barbetti V, Riverso M, Dello Sbarba P, Rovida E.

PLoS One. 2011;6(11):e27450. doi: 10.1371/journal.pone.0027450. Epub 2011 Nov 9.

PMID:
22096574
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, Rugo HS, Hwang ES, Jirström K, West BL, Coussens LM.

Cancer Discov. 2011 Jun;1(1):54-67. doi: 10.1158/2159-8274.CD-10-0028. Epub 2011 Jun 1.

PMID:
22039576
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.

Espinosa I, Edris B, Lee CH, Cheng HW, Gilks CB, Wang Y, Montgomery KD, Varma S, Li R, Marinelli RJ, West RB, Nielsen T, Beck AH, van de Rijn M.

Am J Pathol. 2011 Oct;179(4):2100-7. doi: 10.1016/j.ajpath.2011.06.021. Epub 2011 Aug 18.

PMID:
21854753
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Vascularity of nongynecological leiomyosarcoma depends on colony-stimulating factor 1 but not on vascular endothelial growth factor.

Kubota Y, Suda T.

Am J Pathol. 2011 Oct;179(4):1591-3. doi: 10.1016/j.ajpath.2011.07.008. Epub 2011 Aug 10. No abstract available.

PMID:
21839060
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.

Mills AM, Beck AH, Montgomery KD, Zhu SX, Espinosa I, Lee CH, Subramanian S, Fletcher CD, van de Rijn M, West RB.

Am J Surg Pathol. 2011 Apr;35(4):583-9. doi: 10.1097/PAS.0b013e318211abd6.

PMID:
21412072
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor.

Cheng H, Clarkson PW, Gao D, Pacheco M, Wang Y, Nielsen TO.

Sarcoma. 2010;2010:174528. doi: 10.1155/2010/174528. Epub 2010 Oct 13.

PMID:
20981142
[PubMed]
Free PMC Article
11.

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.

Beck AH, Lee CH, Witten DM, Gleason BC, Edris B, Espinosa I, Zhu S, Li R, Montgomery KD, Marinelli RJ, Tibshirani R, Hastie T, Jablons DM, Rubin BP, Fletcher CD, West RB, van de Rijn M.

Oncogene. 2010 Feb 11;29(6):845-54. doi: 10.1038/onc.2009.381. Epub 2009 Nov 9.

PMID:
19901961
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk